Companies / Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc.
Nasdaq: PRAXCIK 1689548BOSTON, MA
Financials · FY2025
Ownership
27.9M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 0.72% | 201,438 |
| 10%+ / strategic | 9.34% | 2,608,437 |
| Institutions | 105.49% | 29,452,298 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Souza MarcioCEOChief Executive Officer · Director | 0.28% | 76,890 |
Kelly Timothy EdwinChief Financial Officer | 0.11% | 31,046 |
Sniecinski MeganChief Operating Officer | 0.10% | 28,530 |
Nemiroff AlexGeneral Counsel and Secretary | 0.09% | 25,933 |
Mitchell Dean JDirector | 0.07% | 18,622 |
Mastrocola LaurenPrincipal Accounting Officer | 0.05% | 13,446 |
Young William DDirector | 0.01% | 3,269 |
Kindler Jeffrey BDirector | <0.01% | 2,537 |
Arbuckle Stuart ADirector | <0.01% | 1,166 |
Institutional holders 261
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.11B | 12.39% | |
| $767.53M | 8.21% | |
| $655.97M | 7.29% | |
| $564.86M | 6.28% | |
| $430.60M | 5.23% | |
| $400.46M | 4.87% | |
| $369.95M | 4.50% | |
| $343.66M | 3.68% | |
| $310.38M | 3.45% | |
| $280.00M | 3.40% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Baker Bros. Advisors LP 13F manager | Add | Common stock | $201.92M | +627K +55.63% | 1,753,198 6.28% of shares | high |
| Q4 2025 as of | Barclays PLC 13F manager | Add | Common stock | $133.85M | +454K +592.55% | 530,751 1.90% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $71.67M | +214K +10.30% | 2,292,585 8.21% of shares | high |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | Common stock | $70.43M | +219K +6.75% | 3,458,863 12.39% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $48.29M | +144K +16.35% | 1,026,443 3.68% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Trim | Common stock | $-48.19M | -150K -15.49% | 815,739 2.92% of shares | medium |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $44.61M | +138K +2993.00% | 143,082 0.51% of shares | medium |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common stock | $28.53M | +89K +15.74% | 650,904 2.33% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Perceptive Advisors LLC | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G/A | — |
| Fmr LLC | Passive13G | — |
| Orbis Investment Management Ltd | Passive13G | — |
| Baker Bros. Advisors LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PRAX | — | 74006W207 |